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PrevalenceObjective/background: The prevalence of pulmonary nontuberculous mycobacterial (pNTM)
disease, including Mycobacterium avium complex (MAC), varies widely according to geo-
graphic region. However, the factors that influence regional variations in pNTM disease
prevalence remain unknown. This study was undertaken to examine whether environmen-
tal or occupational factors or host traits could influence regional variations in pNTM dis-
ease prevalence.
Methods: We collected laboratory data on pulmonary tuberculosis (pTB) and pNTM from
two hospitals in the West Harima area of Japan and five hospitals in Kyoto City, Japan from
2012 to 2013. We estimated microbiological pNTM disease prevalence by multiplying all pTB
cases in each area with the ratio of pNTM cases and pTB cases at the survey hospitals in
each area. We administered a standardized questionnaire to 52 patients and 120 patients
with pulmonary MAC (pMAC) disease at Ako City Hospital and Kyoto University Hospital,
respectively.School of
I n t e r n a t i o n a l J o u r n a l o f M y c o b a c t e r i o l o g y 5 ( 2 0 1 6 ) 1 7 0 –1 7 6 171Results: The estimated prevalence of microbiological pNTM disease in the West Harima
area (85.4/100,000 population-years) was significantly higher than that observed in Kyoto
City (23.6/100,000 population-years; p < .001). According to multiple logistic regression anal-
ysis, in Ako City Hospital, primary (activities directly related to natural resources) and sec-
ondary industries (construction, mining, and manufacturing primary industry produce;
odds ratio [OR] = 4.79; 95% confidence interval [CI] = 1.49  14.0; p = .007) and soil exposure
(OR = 13.6; 95% CI = 4.94  45.26; p < .001) were associated with pMAC disease.
Conclusion: Environmental factors, both industrial structures associated with occupational
dust and environmental soil exposure, could influence the regional variations in pNTM dis-
ease prevalence.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
All rights reserved.Introduction
Pulmonary nontuberculous mycobacterial (pNTM) disease is
recognized because of its increasing prevalence, particularly
in developed countries [1]. Recently, in Japan, Morimoto
et al. [2] estimated pNTM disease prevalence to be 33–
65/100,000 population-years.
NTM species, including Mycobacterium avium complex
(MAC), are broadly observed in the environment, particularly
in aerosols generated from colonized soil and water [3].
Therefore, the risk of acquiring pNTM disease is associated
with environmental factors, including climate and soil char-
acteristics and the engagement in aerosol-generating occupa-
tions (e.g., agriculture and construction works) and other
activities [4–12]. Furthermore, the risk of acquiring pNTM dis-
ease is also associated with host factors (e.g., racial differ-
ences, female gender, advanced age, skeletal abnormalities,
underlying diseases, and the use of inhaled corticosteroid
and immunomodulatory drugs) [13–16].
pNTM disease prevalence varies widely according to the
geographic region. Some reports showed that the regional
variations in pNTM disease prevalence were correlated with
host factors, both race and income, while others revealed that
they were associated with environmental factors, both cli-
mate and soil characteristics. Therefore, whether environ-
mental or host factors can influence the regional variations
in pNTM disease prevalence remains unknown [17–21]. Fur-
thermore, the effects of other host (e.g., underlying diseases
and medications) and environmental factors (e.g., occupa-
tions and frequency of exposure to soil and water) on regional
variations in pNTM disease prevalence have not been
investigated.
In this study, we first examined pNTM disease prevalence
in the West Harima area (rural area with a small population)
and Kyoto City (urban area with a large population) in Japan.
Here, we estimated pNTM disease prevalence in each area by
the correction with numbers of pulmonary tuberculosis (pTB)
patients according to previous reports [22,23]. Next, using
clinical data and a questionnaire, we examinedwhether envi-
ronmental and host factors could influence the regional vari-
ations in pNTM disease prevalence.Materials and methods
Study area
The population of West Harima area, including Ako city, Aioi
City, and Ako County, was 96,489 in 2012 and 95,527 in 2013.
The population in Kyoto City was 1,473,069 in 2012 and
1,470,730 in 2013. The West Harima area has a Seto Inland
Sea climate, which is observed around the region of the Seto
Inland Sea, and a mild and sunny climate characterized by
low rainfall in August. The annual precipitation, mean
humidity, and mean maximal and minimal temperatures in
the West Harima area are approximately 1200 mm, 71%,
20.2 C, and 10.8 C, respectively. Kyoto City has both a Seto
Inland Sea climate and inland climate, as typified by a hot
summer and cold winter. The annual precipitation, mean
humidity, and mean maximal and minimal temperatures of
Kyoto City are approximately 1500 mm, 71%, 20.8 C, and
11.7 C, respectively.
Industrial structure
We divided the industrial structure into three categories
based on the national census as follows: primary industry
(activities directly related to natural resources, e.g., agricul-
ture, forestry, and fishery); secondary industry (construction,
mining, and manufacturing industry product); and tertiary
industry (services) [24]. The results of a national census taken
in 2010 revealed that in the West Harima area, 2.1%, 34.6%,
and 63.3% of the population was engaged in primary, sec-
ondary, and tertiary industries as compared to 0.9%, 21.7%,
and 77.5%, respectively, in Kyoto City [24].
Data collection
We collected microbiological data for all culture-positive acid-
fast bacilli to examine the numbers of patients with pNTM
disease who met the American Thoracic Society microbiolog-
ical criteria (microbiological pNTM disease) [25] from two
local hospitals [Ako City Hospital (396 beds) and Ako Central
Hospital (265 beds)] in the West Harima area and five medical
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Hospital, Kyoto Prefectural University of Medicine (1065 beds),
Kyoto Katsura Hospital (585 beds), Kyoto City Hospital (548
beds), and National Hospital Organization Kyoto Medical Cen-
ter (600 beds)] in Kyoto City from 2012 to 2013. In Japan, every
diagnosed case of TB was reported by a clinician to the local
public health office, because notification of TB cases is
mandatory. Data for all culture-positive pTB cases were
obtained from each public health office in the West Harima
area and Kyoto City, respectively. Isolates that could not be
discriminated between M. avium and M. intracellulare were
designated as unspecified MAC.
We also examined the characteristics of patients with pul-
monary MAC (pMAC) disease in the West Harima area and
Kyoto City. In total, 52 patients with pMAC disease who lived
in Ako city or Ako County were followed at Ako City Hospital
between January 2012 and November 2013, and 120 patients
with pMAC disease who lived in Kyoto City were followed at
Kyoto University Hospital over the same period. Ako City
Hospital and Kyoto University Hospital are the local central
hospitals in each area. The diagnosis of pMAC disease was
based on the ATS criteria [25]. Clinical data, including demo-
graphic characteristics, the presence of underlying diseases
and conditions, and the microbiological results for respiratory
specimens, were collected from clinical records. All partici-
pants completed a standardized questionnaire that included
questions about their experiences, such as occupations, soil
exposure from farming or gardening, and water exposure
from taking baths, showering, hot tub use, washing dishes,
or swimming in a pool [4,5]. High soil exposure was defined
as P2 h/wk of soil-related activities. Chest radiographs and
computed tomography (CT) scans were reviewed by two pul-
monary clinicians. The review board of Kyoto University
Hospital approved the research protocol (E1773 and E1905).
Estimated prevalence of microbiological pNTM disease
To estimate microbiological pNTM disease prevalence, we
used the following equation according to previous reports
[22,23]:
X Z=Y ¼ P; ð1Þ
where X is the incidence of culture-positive pTB (per
100,000 population-years) in each area, Y is the number of
patients diagnosed with culture-positive pTB at the survey
hospitals in each area, Z is the number of patients with micro-
biological pNTM disease at the survey hospitals in each area,
and P is the estimated prevalence of microbiological pNTM
disease in each area.
2.5. Statistical analysis
To determine which variables could determine the regional
variations in pNTM disease prevalence, we first compared
the characteristics of patients with pMAC disease between
the West Harima area and Kyoto City. Categorical and contin-
uous variables were compared using the chi-square test and
Wilcoxon’s test, respectively, followed by multiple logistic
regression analysis. The variables entered in the multivariate
analysis were those yielding a p < .05 on univariate analysis. Ap < .05 was considered significant. All statistical analyses
were performed using JMP 10 software (SAS Institute Inc.,
Cary, NC, USA).
3. Results
3.1. Estimated prevalence of microbiological pNTM
disease
Table 1 describes the estimated prevalence of microbiological
pNTM disease in the West Harima area and Kyoto City. The
numbers of culture-positive pTB cases registered in each pub-
lic health office from 2012 to 2013 were 32 and 568 in the West
Harima area and Kyoto City, respectively. The incidences of
culture-positive pTB in the West Harima area and Kyoto City
were 16.7/100,000 population-years and 19.3/100,000
population-years, respectively. The numbers of patients with
culture-positive pTB recorded the hospitals in the West Har-
ima area and Kyoto City were 9 (7 in Ako City Hospital and
2 in Ako Central Hospital) and 203 (82 in Kyoto University
Hospital, 7 in University Hospital, Kyoto Prefectural Univer-
sity of Medicine, 10 in Kyoto-Katsura Hospital, 82 in Kyoto
City Hospital, and 22 in National Hospital Organization Kyoto
Medical Center), respectively. The numbers of patients with
microbiological pNTM disease in the West Harima area and
Kyoto City were 46 (45 in Ako City Hospital and 1 in Ako Cen-
tral Hospital) and 248 (147 in Kyoto University Hospital, 1 in
University Hospital, Kyoto Prefectural University of Medicine,
47 in Kyoto-Katsura Hospital, 36 in Kyoto City Hospital, and 17
in National Hospital Organization Kyoto Medical Center),
respectively. Using Eq. (1), the estimated prevalence of micro-
biological pNTM disease in the West Harima area
(85.4/100,000 population-years) was significantly higher than
that in Kyoto City (23.6/100,000 population-years; p < .001).
Patients diagnosed with microbiological pNTM disease in
theWest Harima areaweremore elderly comparedwith those
in Kyoto City (74.6 ± 9.6 years vs. 70.2 ± 9.3 years; p = .011). In
both areas, female gender predominated (71.7% in West Har-
ima area and 65.7% in Kyoto City). The diagnostic sources in
the West Harima area were sputum, specimens obtained
through bronchoscopy, and lung tissue in 44 patients, 2
patients, and 0 patients, versus 212 patients, 31 patients,
and 5 patients, respectively, in Kyoto City. In the West Harima
area and Kyoto City, MAC accounted for >90% of NTM species
(91.3% and 91.8%, respectively), followed byM. abscessus (4.4%
and 3.6%, respectively), and M. kansasii (2.2% and 3.2%,
respectively; Fig. 1).
3.2. Characteristics of patients with pMAC disease
The characteristics of patients with pMAC disease in Ako City
Hospital and Kyoto University Hospital are shown in Table 2.
Patients in Ako City Hospital tended to be older than those in
Kyoto University Hospital (67.0 ± 8.8 years vs. 63.2 ± 9.9 years;
p = .051). In both hospitals, there were no differences in body
shape, and female gender predominated. Regarding CT find-
ings, in Kyoto University Hospital, a cavitary form was found
to be more frequent than that observed at Ako City Hospital
(25.8% vs. 9.6%; p = .016).
Fig. 1 – Species distribution in patients with microbiological
pulmonary nontuberculous mycobacterial disease. In both
the West-Harima area and Kyoto City in Japan,
Mycobacterium avium complex accounted for >90% of
nontuberculous mycobacterial species. Note. M,
Mycobacterium; MAC, Mycobacterium avium complex.
aIsolates that could not be discriminated between M. avium
and M. intracellulare were designated as Unspecified MAC.
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patients with pMAC disease in Ako City Hospital and Kyoto
University Hospital are presented in Table 3. More patients
in Ako City Hospital experienced high soil exposure (P2 h/
wk) as compared to those in Kyoto University Hospital
(63.5% vs. 23.3%; p < .001). Concerning the source of soil expo-
sure, in Ako City Hospital, farming was a more frequent
source of exposure than that observed in Kyoto University
Hospital (36.5% vs. 8.3%; p < .001). Regarding water exposure,
patients in Kyoto University Hospital used showers more fre-
quently than those in Ako City Hospital (66.7% vs. 15.4%;
p < .001). More patients with pMAC disease in Ako City Hospi-
tal were engaged in primary (9.6% vs. 0.8%; p = .004) and sec-
ondary industries (32.7% vs. 10.8%; p = .005) than those
observed in Kyoto University Hospital.
By multiple logistic regression analysis, we determined
that primary and secondary industries (odds ratios [OR]
= 4.79; 95% confidence interval [CI] = 1.49  14.0; p = .007) and
high soil exposure (OR = 13.6; 95% CI = 4.94  45.26; p < .001)
were associated with pMAC disease in Ako City Hospital
(Table 4).
4. Discussion
We revealed that the estimated prevalence of microbiological
pNTM disease was significantly higher in the West Harima
area than in Kyoto City. This difference was influenced by
the engagement in industries associated with occupational
dust and experience of high soil exposure (P2 h/wk). To our
knowledge, this is the first report revealing the impact of
Table 2 – Clinical data of the patients with pulmonary Mycobacterium avium complex disease in Ako City Hospital and Kyoto
University Hospital in Japan.
Ako City Hospital Kyoto University Hospital p
(n = 52) (n = 120)
Gender, female 37 (71.2) 93 (77.5) .37
Age (y) 67.0 ± 8.8 63.2 ± 9.9 .051
Height (m) 1.58 ± 0.08 1.58 ± 0.09 .67
Weight (kg) 49.5 ± 9.2 48.7 ± 8.6 .31
BMI (kg/m2) 19.8 ± 2.8 19.6 ± 2.4 .72
Smoking status, current/ex/never 2/12/38 3/21/96 .60
Alcohol drinking habita 14 (26.9) 29 (24.8) .77
Past history
Previous tuberculosis 1 (1.9) 12 (10) .066
Bronchial asthma 3 (5.8) 9 (7.5) .68
Chronic obstructive pulmonary disease 5 (9.6) 5 (4.2) .16
Interstitial lung disease 0 (0) 2 (1.7) .35
Previous malignant disease 4 (7.7) 21 (17.5) .094
Diabetes mellitus 4 (7.7) 12 (10) .63
Chronic liver disease 2 (1.2) 7 (5.8) .59
Chronic renal disease 1 (1.9) 0 (0) .13
Autoimmune disease 3 (5.8) 8 (6.7) .83
Medication
Acid-suppressive drug useb 5 (9.6) 11 (9.2) .93
Inhaled corticosteroid 7 (13.5) 7 (5.8) .093
Immunosuppressive agents 2 (3.9) 6 (5) .74
NTM species
M. avium 32 (61.5) 84 (70) .29
M. intracellulare 19 (36.5) 35 (29.2)
M. avium + M. intracellulare 0 (0) 1 (0.8)
Unspecified MACc 1 (1.9) 0 (0)
Radiographic finding
Cavitary form 5 (9.6) 31 (25.8) .016
Note: Data are presented as the mean ± standard deviation or n (%). BMI, body mass index; MAC, Mycobacterium avium complex; NTM, non-
tuberculous mycobacterial; y = year.
a Drinking alcohol at least once per week.
b Proton pump inhibitor and histamine type-2 receptor antagonists are included.
c Isolates that could not be discriminated between M. avium and M. intracellulare were designated as unspecified MAC.
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regional variations in pNTM disease prevalence using a
questionnaire.
In this study, we first revealed that environmental factors,
both the industrial structure with a high rate of primary and
secondary industries and frequencies exposed to soil, but not
host factors, were associated with regional variations in
pNTM disease prevalence. Previous reports showed that
regional variations in pNTM disease prevalence were associ-
ated with environmental factors, both climate (e.g., high
moisture) and soil characteristics [19,20]. Concerning the
associations of industry with pNTM infections, Reed et al.
[11] reported that occupations involving prolonged soil expo-
sure (e.g., farming) increased the risk of pMAC infection [11].
Additionally, tunnel work and mining, including dusty jobs
involving silica dust inhalation, increase the risk of pNTM dis-
ease [26,27]. Concerning the associations of soil exposure
with pNTM infections, we reported that environmental soil
exposure was an independent risk factor for pMAC disease
and the development of polyclonal and mixed MAC infections
[4,6,7]. Additionally, we reported that low soil exposure wasassociated with better microbiological outcomes in patients
with pMAC disease [5].
We estimated pNTM disease prevalence in each area by
correction with numbers of pTB patients according to previ-
ous reports [23,25], because it is difficult to determine the pre-
cise prevalence of pNTM disease. In this study, the estimated
prevalence of microbiological pNTM disease in the West Har-
ima area and Kyoto City was 85.4/100,000 population-years
and 23.6/100,000 population-years, respectively. The overall
prevalence in the two areas was 26.5/100,000 population-
years. Recently, Morimoto et al. [2] reported that pNTM dis-
ease prevalence calculated from mortality rates ranged from
33–65/100,000 population-years in Japan [2]. In North Amer-
ica, Europe, Australia, and other Asian countries than Japan,
previous studies reported that pNTM disease prevalence ran-
ged from 3 population-years to 14.1/100,000 population-years
[28–34]. In Japan, pNTM disease prevalence was suspected to
be higher than that in most other countries.
This study had some limitations. First, we evaluated only
two areas, namely the West Harima area and Kyoto City. Sec-
ond, we only identified nine patients with culture-positive
Table 3 – Environmental exposure and industrial structures in patients with pulmonary Mycobacterium avium complex
disease in Ako City Hospital and Kyoto University Hospital in Japan.
Ako City Hospital Kyoto University Hospital p
(n = 52) (n = 120)
Environmental exposure
Soil exposure
High (P2 h/wk) 33 (63.5) 28 (23.3) <.001
Farming 19 (36.5) 10 (8.3) <.001
Gardening 29 (55.8) 55 (45.8) .23
Water exposure
Bathing (P1/d) 39 (75.0) 79 (65.8) .23
Shower use in a bathroom 8 (15.4) 80 (66.7) <.001
Hot tub usea 1 (1.9) 6 (5.6) .29
Dishwashing (P3/d) 35 (67.3) 75 (62.5) .55
Swimming in a pool 4 (7.7) 8 (6.7) .81
Industrial structure
Primary industryb 5 (9.6) 1 (0.8) .004
Secondary industryc 17 (32.7) 13 (10.8) .005
Tertiary industryd 26 (50.0) 68 (56.7) .42
Note: Data are presented as the mean ± standard deviation or n (%). d, day; wk, week.
a Hot tub with jetted or agitated water.
b Agriculture, forestry, and fisheries.
c Construction, mining, and goods production in the economy, including the processing of materials produced by primary industry.
d Services.
Table 4 – Factors associated with pulmonary Mycobacterium avium complex disease in Ako City Hospital in Japan.
Variable Univariate analysis Multivariate analysis
OR (95% CI) p OR (95% CI) p
Cavitary form 0.31 (0.0990.78) .016 0.23 (0.0710.67) .016
Primary & secondary industries 5.55 (2.5412.15) <.001 4.79 (1.4914.0) .007
High soil exposure 5.71 (2.8211.55) <.001 13.6 (4.9445.26) <.001
Shower use in bathroom 0.091 (0.0370.20) <.001 0.046 (0.0130.13) <.001
Note: CI, confidence interval; OR, odds ratio.
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public health office in this area reported 32 patients. Third, in
the West Harima area, more people engaged in primary and
secondary industries as compared to Kyoto City (2.1% vs.
0.9% and 34.6% vs. 21.7%, respectively) [24]. Therefore, this
industrial background could have influenced our results.
Future studies comprising many regions having similar
industrial structures are needed. Finally, we conducted a
questionnaire survey at only one hospital each in the West
Harima area (Ako City Hospital) and Kyoto City (Kyoto Univer-
sity Hospital). Each hospital covered more than half of the
patients with microbiological NTM disease in this study; par-
ticularly, Ako City Hospital and Kyoto University Hospital cov-
ered 97.8% and 59.3%, respectively, of the patients with
microbiological NTM disease. However, it is possible that
the clinical data obtained for each area does not reflect the
characteristics of the entire region.
5. Conclusion
We concluded that environmental factors, both industrial
structures associated with occupational dust and environ-mental soil exposure, could influence the regional variations
in pNTM disease prevalence. Future studies comprising many
regions and hospitals are needed to reveal the effect of indus-
trial structure on the regional prevalence of pNTM disease.
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